Core Laboratories Inc. /De/
CLB
Revenue
134.40M
▲3.82M▲2.93%
3 Months ChangeAssets
600.47M
▲2.67M▲0.4461%
3 Months ChangeLiabilities
349.72M
▼-7.80M▼-2.18%
3 Months ChangeFree Cash Flow
2.48M
▲7.86M▲146.09%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-24
Form 10-Q
ID: 0000950170-24-117122
2024-10-23
Form 8-K
ID: 0000950170-24-116676
2024-07-25
Form 10-Q
ID: 0000950170-24-086610
2024-07-24
Form 8-K
ID: 0000950170-24-086092
2024-05-10
Form 8-K
ID: 0000950170-24-057934
2024-04-25
Form 10-Q
ID: 0000950170-24-048414
2024-04-24
Form 8-K
ID: 0000950170-24-047646
2024-03-25
Form 8-K
ID: 0000950170-24-035962
2024-01-31
Form 8-K
ID: 0000950170-24-009489
2023-11-02
Form 10-Q
ID: 0000950170-23-058206